Cymbalta Once-Daily Dosing Not Vital To Product's Success, Lilly Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly says it has data on twice-daily Cymbalta dosing, and analysts express concern that the company has not previously discussed the possibility of b.i.d. administration in labeling. Exec VP-Science & Technology Paul maintains Cymbalta is also "very effective and very safe" taken once a day.
You may also be interested in...
Lilly Highlighting Once-Daily Cymbalta Dose
Lilly will focus on the 60 mg once a day dose of Cymbalta in detailing the antidepressant to prescribers
Lilly Highlighting Once-Daily Cymbalta Dose
Lilly will focus on the 60 mg once a day dose of Cymbalta in detailing the antidepressant to prescribers
EntreMed Panzem To Boost Bioavailability Under Elan Supply Deal
Elan will reformulate and manufacture Panzem (2-methoxyestradiol) as an oral liquid formulation using its NanoCrystal technology. EntreMed expects to initiate a clinical oncology program in 2005 using the new formulation.